Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Mar 18:10:1383.
doi: 10.3389/fgene.2019.01383. eCollection 2019.

A New Mutation in IDS Gene Causing Hunter Syndrome: A Case Report

Affiliations
Case Reports

A New Mutation in IDS Gene Causing Hunter Syndrome: A Case Report

Caio Perez Gomes et al. Front Genet. .

Abstract

Rationale: Mucopolysaccharidosis type II (Hunter syndrome) is an X-linked multisystem disorder, caused by deficiency of the lysosomal enzyme iduronate-2-sulfatase (I2S). The clinical manifestations of this disease are severe skeletal deformities, airway obstruction, cardiomyopathy, and neurologic deterioration.

Patient: The patient was 5 years and 6 months boy, with developmental delay, hearing loss, hepatosplenomegaly, and skeletal dysplasia. He was diagnosed with mucopolysaccharidosis type II based on clinical manifestations, biochemical and genetic analysis.

Outcomes: The patient carries a new mutation (c.879-1210_1007-218del) in hemizygosis in the IDS gene, which was defined as pathogenic according to the 2015 American College of Medical Genetics and Genomics-Association for Molecular Pathology guidelines and as responsible for the mucopolysaccharidosis type II phenotype in the patient.

Keywords: Hunter syndrome; IDS; iduronate-2-sulfatase; inborn errors of metabolism; lisossomal storage disease; mucopolysaccharidosis type II.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient's dysmorphic facial features—broad nasal bridge, large rounded cheeks, and thick large lips.
Figure 2
Figure 2
Patient's radiographic findings. (A) Proximal pointed phalanges of hands. (B) Proximal pointed phalanges of feet. (C) Widened anterior and tapered posterior ribs (arrow). (D) “Beaked vertebra” of lumbar spine (arrow).
Figure 3
Figure 3
(A) IDS gene molecular structure. The red arrows show the breakpoints of the deletion observed in the patient (4,335 bp). (B) Electrophoresis of a long range PCR, showing the amplified fragment spanning from exon 6 to 8 (Fragment size: normal control 9,801 bp and patient 5,466 bp). (C) Sequence obtained from the genomic DNA of the patient shows the junction between intron 6 and 7 of the IDS gene (total deletion of exon 7).
Figure 4
Figure 4
Reverse transcriptase (RT) for IDS gene from total blood RNA obtained from the patient and his mother. (A) PCR fragment from exons 1–9 (expected fragment size 1,775 bp). It is possible to observe the generation of the fragments lacking exons 7 and 8 (1,474 bp) and fragment lacking exons 5, 7, and 8 (1,273 bp). (B) PCR fragment from exons 6 to 9 (expected fragment size 593 bp). It is possible to observe the generation of the fragments lacking exon 7 (466 bp) and fragment lacking exons 7 and 8 (292 bp). The figure depicts the transcript of 1,474 bp lacking exons 7 and 8 (C) and the transcript of 1,273 bp lacking exons 5, 7, and 8 (D).

Similar articles

Cited by

References

    1. Amiñoso C., Vallespin E., Fernández L., Arrabal L. F., Desviat L. R., Pérez B., et al. (2013). Identification of the first deletion–insertion involving the complete structure of GAA gene and part of CCDC40 gene mediated by an Alu element. Genetics 519, 169–172. - PubMed
    1. Birot A. M., Bouton O., Froissart R., Maire I., Bozon D. (1996). IDS Gene-Pseudogene exchange responsible for an intragenic deletion in a hunter patient. Hum. Mutat. 8, 844–850. - PubMed
    1. Galvis J., Gonzáles J., Uribe A., Velasco H. (2015). Deep Genotyping of the IDS Gene in Colombian Patients with Hunter Syndrome. JIMD Rep. February, 19, 101–109. - PMC - PubMed
    1. Garland J., Stephen J., Class B., Gruber A., Ciccone C., Poliak A., et al. (2017). Identification of an Alu element-mediated deletion in the promoter region of GNE in siblings with GNE myopathy. Mol. Genet. Genomic Med. 5, 410–417. - PMC - PubMed
    1. Giugliani R., Villarreal M. L. S., Valdez C. A. A., Hawilou A. M., Guelbert M., Garźon L. N. C., et al. (2014). Guidelines for diagnosis and treatment of hunter syndrome for clinicians in Latin America. Genet. Mol. Biol. 37, 315–329. - PMC - PubMed

Publication types

LinkOut - more resources